sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - okužbe z virusom hiv - antivirusi za sistemsko uporabo - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 in 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 in 5.
bortezomib teva 3,5 mg prašek za raztopino za injiciranje
teva b.v. - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib
ringerjeva raztopina braun raztopina za infundiranje
b. braun melsungen ag - kalcijev klorid dihidrat; natrijev klorid - raztopina za infundiranje - kalcijev klorid dihidrat 0,33 mg / 1000 ml natrijev klorid8,6 mg / 1000 ml; natrijev klorid 8,6 mg / 1000 ml - elektroliti
bortezomib actavis 3,5 mg prašek za raztopino za injiciranje
actavis group ptc ehf. - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib
ringerjeva raztopina braun raztopina za infundiranje
b. braun melsungen ag - kalcijev klorid dihidrat; natrijev klorid - raztopina za infundiranje - kalcijev klorid dihidrat 0,33 mg / 1000 ml natrijev klorid8,6 mg / 1000 ml; natrijev klorid 8,6 mg / 1000 ml - elektroliti
deltyba
otsuka novel products gmbh - delamanid - tuberkuloza, odporna proti multidrugom - antimikobakterij - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
bortezomib sandoz 3,5 mg prašek za raztopino za injiciranje
sandoz d.d. - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib
bortezomib ebewe 3,5 mg prašek za raztopino za injiciranje
ebewe pharma - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib
bortezomib pharmaswiss 3,5 mg prašek za raztopino za injiciranje
pharmaswiss Česká republika s.r.o. - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib
rukobia
viiv healthcare b.v. - fostemsavir trometamol - okužbe z virusom hiv - antivirusi za sistemsko uporabo - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.